NIPHS (Non-insulinoma pancreatogenous hypoglycemia) This refers to islet cell hypertrophy without a distinct insulinoma
Administering the peptide in the PWO window (typically within an hour) could, in theory, lead to a more pronounced local anabolic effect
Diabetes (2009) 58:97583
Anbazhagan AN, Thaqi M, Priyamvada S, Jayawardena D, Kumar A, Gujral T, Chatterjee I, Mugarza E, Saksena S, Onyuksel H, Dudeja PK
Currently, a 52-week Phase 2 clinical trial (NCT05669599) is underway for the overweight and obese population to further evaluate the safety and long-term efficacy of AMG133
Reference: Cox, H., Miller, G., & Eichner, D